Found: 12
Select item for more details and to access through your institution.
Development of a Potency Assay for Nous-209, a Multivalent Neoantigens-Based Genetic Cancer Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 325, doi. 10.3390/vaccines12030325
- By:
- Publication type:
- Article
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1156714
- By:
- Publication type:
- Article
Adenovirus vectors activate Vδ2<sup>+</sup> γδT cells in a type I interferon‐, TNF‐, and IL‐18‐dependent manner.
- Published in:
- European Journal of Immunology, 2022, v. 52, n. 5, p. 835, doi. 10.1002/eji.202149367
- By:
- Publication type:
- Article
VENUS, a Novel Selection Approach to Improve the Accuracy of Neoantigens' Prediction.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 880, doi. 10.3390/vaccines9080880
- By:
- Publication type:
- Article
In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 7, p. 1, doi. 10.1371/journal.ppat.1009720
- By:
- Publication type:
- Article
Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 3, p. 554, doi. 10.1093/cvr/cvz138
- By:
- Publication type:
- Article
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/6051870
- By:
- Publication type:
- Article
Longitudinal transcriptomic and genetic landscape of radiotherapy response in canine melanoma.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 3, p. 308, doi. 10.1111/vco.12473
- By:
- Publication type:
- Article
Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10594-2
- By:
- Publication type:
- Article
A novel ErbB2 epitope targeted by human antitumor immunoagents.
- Published in:
- FEBS Journal, 2011, v. 278, n. 7, p. 1156, doi. 10.1111/j.1742-4658.2011.08041.x
- By:
- Publication type:
- Article
Differential binding of human immunoagents and Herceptin to the ErbB2 receptor.
- Published in:
- FEBS Journal, 2008, v. 275, n. 20, p. 4967, doi. 10.1111/j.1742-4658.2008.06625.x
- By:
- Publication type:
- Article
Intracellular route and mechanism of action of ERB-hRNase, a human anti-ErbB2 anticancer immunoagent
- Published in:
- FEBS Letters, 2007, v. 581, n. 2, p. 296, doi. 10.1016/j.febslet.2006.12.034
- By:
- Publication type:
- Article